Common antidepressant may ease long COVID’s crushing fatigue
3 Articles
3 Articles
Common Antidepressant Pill Found Effective Against Long Covid Fatigue: Study
A new controlled trial finds a common mental health pill effective in treating long Covid fatigue. This result marks a significant step toward managing ongoing symptoms, although further clinical...
Common antidepressant may ease long COVID’s crushing fatigue
A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue. In a randomized clinical trial involving 399 adults, fluvoxamine significantly reduced fatigue and improved quality of life compared with a placebo, making it one of the first medications to show meaningful benefits for this disabling condition.
A recent study indicates that fluvoxamine, a widely used antidepressant, may offer significant relief for patients suffering from persistent fatigue associated with long COVID. The research, conducted by an international team including McMaster University, revealed that the drug not only reduces fatigue but also improves the quality of life of those affected. The clinical trial, involving 399 adults with long COVID, demonstrated that fluvoxamine…
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
